WASHINGTON (Reuters) – Theranos Inc and its Chief Executive Elizabeth Holmes have agreed to settle “massive fraud” charges in a deal that strips her of majority control over the embattled blood-testing company, among other penalties, U.S. regulators said on Wednesday.
Powered by WPeMatico